Transaction · 0001695028-26-000006

Piscitelli Dominic

Piscitelli Dominic, CFO, reported an open-market or private sale at Oric Pharmaceuticals, Inc. involving 77000.000000 shares for an estimated $1053814.30. Reported holdings after the transaction were 69828.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
ORICOric Pharmaceuticals, Inc.
Trade date
Aug 26, 2026
Filing date
Aug 28, 2026
View on SEC Insider profile
Estimated value-$1.05MShares × reported price
Shares traded77.0k$13.69 per share
Holdings after69.8kDirect
% of reported position traded52.44%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 146,828 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ORIC price since this filing

Daily closing prices, with the filing date and available return windows
ORIC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -2.9%30d -0.6%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001695028-26-000006
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 28, 2026, 08:11 PM · 2d delay
Shares
77,000 sh
$13.69 per share
Estimated value
-$1.05M
Computed from shares × price
Holdings after
69,828 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction Large Sale 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.

  2. F2

    The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.

  3. F3

    25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.

Original filing · 0001695028-26-000006
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ORIC